Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Tue, Sep 15, 2026
5:00 – 6:00 AM Bangkok
Second Opinions: When to Seek One and How to Involve Your Care Team
Taimur Sher
Click Here To Register
View all
UPCOMING SESSIONS
in
ET
Tue, Sep 15, 2026 · 5:00 – 6:00 AM Bangkok
Second Opinions: When to Seek One and How to Involve Your Care Team
Taimur Sher
Click Here To Register
View all sessions
All Upcoming Sessions
3
SEP
15
Second Opinions: When to Seek One and How to Involve Your Care Team
Tue, Sep 15, 2026 · 5:00 – 6:00 AM Bangkok
Taimur Sher
Register
SEP
15
Newly Diagnosed Amyloidosis Patient Welcome Session
Tue, Sep 15, 2026 · 10:00 – 12:00 AM Bangkok
Stacey Goodman
Register
SEP
17
Ask the Hematologist: Your AL Amyloidosis Questions Answered
Thu, Sep 17, 2026 · 5:00 – 6:00 AM Bangkok
Morie A. Gertz
Register
Dexamethasone
Home
Dexamethasone
Jun 03, 2018
Subcutaneous Daratumumab (DARA SC) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (Cybord) in Patients (Pts) With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Safety Run-in Results of Andromeda
Background: Systemic AL amyloidosis is characterized by disposition of insoluble amyloid fibrils into tissues and organs via clonal expansion of CD38+ plasma cells…
Read more
Subscribe to
